茵栀黄颗粒治疗酒精性肝病的药效学、网络药理学与分子对接研究
本研究结合液质联用、药效学、网络药理学和分子对接,探讨茵栀黄颗粒对酒精性肝病的作用机制。在酒精性肝病小鼠中,茵栀黄颗粒可改善肝功能、减轻肝组织病变、降低肝脏炎症与氧化应激;网络药理学提示其主要通过调控PI3K-Akt等炎症相关信号通路发挥作用,SRC、HSP90AA1、STAT3、EGFR和AKT1可能为关键靶点。
要点
- 茵栀黄颗粒可改善酒精性肝病小鼠肝功能与肝组织病变。
- 其作用可能与调控PI3K-Akt等炎症相关信号通路有关。
- SRC、HSP90AA1、STAT3、EGFR和AKT1可能为关键靶点。
核心结论
- 茵栀黄颗粒可能通过多成分、多靶点、多通路调控炎症相关信号通路治疗酒精性肝病。
研究设计与样本
- 研究采用液质联用技术、药效学实验、网络药理学分析和分子对接方法。
- 药效学实验在酒精性肝病小鼠中开展,网络药理学与分子对接用于预测机制。
主要发现
- 液质联用鉴定出茵栀黄颗粒中25种化合物,包括4-羟基苯乙酮、滨蒿内酯、栀子苷、槲皮素、黄芩苷、黄芩素、绿原酸和咖啡酸等。
- 药效学显示茵栀黄颗粒可改善酒精性肝病小鼠肝功能、减轻肝组织病变程度、降低肝脏炎症和氧化应激。
- 网络药理学分析显示茵栀黄颗粒治疗酒精性肝病主要调控PI3K-Akt等炎症相关信号通路。
- PPI网络和分子对接结果显示SRC、HSP90AA1、STAT3、EGFR和AKT1可能是茵栀黄颗粒治疗酒精性肝病的关键靶点。
临床怎么用
- 本研究为茵栀黄颗粒治疗酒精性肝病提供了潜在化合物、靶点和信号通路层面的机制依据。
- 结果有助于阐明茵栀黄颗粒的药效与机制,为其临床应用提供新思路。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Yinzhihuang granules (YZHG) is a commonly used Chinese patent medicine for the treatment of liver disease. However, the mechanism of YZHG in alcoholic liver disease (ALD) is still unclear. METHODS: This study combined liquid chromatography-mass spectrometry technology, pharmacodynamics, network pharmacology and molecular docking methods to evaluate the potential mechanism of YZHG in the treatment of ALD. RESULTS: A total of 25 compounds including 4-hydroxyacetophenone, scoparone, geniposide, quercetin, baicalin, baicalein, chlorogenic acid and caffeic acid in YZHG were identified by ultra performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS). The pharmacodynamic investigations indicated that YZHG could improve liver function and the degree of liver tissue lesions, and reduce liver inflammation and oxidative stress in ALD mice. Network pharmacology analysis showed that YZHG treated ALD mainly by regulating inflammation-related signaling pathways such as the PI3K-Akt signaling pathway. The results of the PPI network and molecular docking showed that the targets of SRC, HSP90AA1, STAT3, EGFR and AKT1 could be the key targets of YZHG in the treatment of ALD. CONCLUSION: This study explored the potential compounds, potential targets and signaling pathways of YZHG in the treatment of ALD, which is helpful to clarify the efficacy and mechanism of YZHG and provide new insights for the clinical application of YZHG.
引用
- Tan Y, Zhang F, Fan X, et al. Exploring the effect of Yinzhihuang granules on alcoholic liver disease based on pharmacodynamics, network pharmacology and molecular docking. Chin Med. 2023. PMID: 37165407. doi:10.1186/s13020-023-00759-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。